NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
CHA University
CHA University
Pfizer
Intergroupe Francophone de Cancerologie Thoracique
Shanghai Zhongshan Hospital
Hoffmann-La Roche
Hoffmann-La Roche
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fundación GECP